Detailed Guide to Bevatas 400mg (Bevacizumab) Injection: Targeted Therapy & Global Supply In the advanced treatment of multiple malignancies, Bevatas 400mg Injection has become a cornerstone of anti-angiogenic therapy. As a specialized Pharmaceutical Exporter from India, Ernest Oncology (Group of Ernest Pharmaceutical Pvt. Ltd.) ensures that healthcare providers in the USA, UK, UAE, Australia, Singapore, South Africa, and across Asia have seamless access to this high-quality Bevacizumab biosimilar. What is Bevatas 400mg (Bevacizumab)? Bevatas is a biosimilar of the monoclonal antibody Bevacizumab. It is a recombinant humanized monoclonal IgG1 antibody that specifically targets and inhibits the Vascular Endothelial Growth Factor (VEGF). By blocking VEGF, the medication prevents the formation of new blood vessels that tumors need to grow and spread—a process known as anti-angiogenesis. Therapeutic Indications Bevatas 400mg is globally recognized for treating several advanced malignancies: Metastatic Colorectal Cancer: Used in combination with 5-fluorouracil-based chemotherapy. Non-Small Cell Lung Cancer (NSCLC): Specifically for non-squamous, metastatic cases. Glioblastoma: For patients with progressive disease following prior therapy. Metastatic Renal Cell Carcinoma (Kidney Cancer): Used in combination with interferon-alpha. Cervical Cancer: For persistent, recurrent, or metastatic cases. Ovarian Cancer: Including fallopian tube and primary peritoneal cancer. Mechanism of Action Bevacizumab works by neutralizing the biological activity of VEGF: Starving the Tumor: By binding to VEGF, it prevents the protein from interacting with its receptors on the surface of endothelial cells. Vascular Regression: It leads to the regression of existing tumor microvasculature. Inhibiting Neovascularization: It prevents the growth of new blood vessels into the tumor, thereby inhibiting tumor growth. Product Specifications & Clinical Usage Technical Specifications Active Ingredient: Bevacizumab (25 mg/mL) Strength: 400 mg / 16 mL single-dose vial. Form: Sterile, preservative-free, clear to slightly opalescent solution. Manufacturer: Intas Pharmaceuticals Ltd. (Marketed globally via Ernest Oncology). Storage: Strict cold-chain maintenance required at 2°C to 8°C (36°F to 46°F). Do not freeze or shake. Protect from light. Dosage and Administration Method: Administered only by a healthcare professional as an Intravenous (IV) Infusion. It must not be administered as an IV push or bolus. Schedule: Depending on the type of cancer and the treatment regimen, it is typically administered every 2 or 3 weeks. First Infusion: The initial dose is usually delivered over 90 minutes; if well-tolerated, subsequent infusions may be shortened. Safety & Side Effects Common side effects may include: Hypertension (High blood pressure). Fatigue and weakness. Nosebleeds (Epistaxis) and headache. Critical Precaution: Bevacizumab can interfere with wound healing. It is generally recommended to wait at least 28 days following major surgery before starting Bevatas, or to stop the medication at least 28 days before an elective surgery. Why Partner with Ernest Oncology for Global Export? Ernest Oncology specializes in the complex logistics required for high-value oncology biologics like Bevatas 400mg. Validated Cold-Chain: We utilize advanced thermal packaging and data loggers to ensure Bevatas 400mg reaches London, Dubai, or Singapore in perfect condition. Bulk Supplier Advantage: We cater to hospital tenders and pharmacy distributors in South Africa, Australia, and the USA, offering competitive pricing on premium Indian biosimilars. Regulatory Expertise: Our team manages all export documentation (CoA, COO) and international shipping protocols for the Middle East, Africa, and Asia. 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us